Dr George Follows speaks with ecancertv at BSH 2016 about the UKCLL session he chaired, reviewing the data presented, the background, and potential clinical applications of current research.

He describes the microenvironment required to sustain CLL in research, having previously been difficult to model and maintain cancer cells in situ.

More of about the microenvironment in vivo is discussed by Dr Jan Burger here.

For ongoing trials in the UK, you can view more from Dr Follows here.

ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.